SCHEMBL20248903

SCHEMBL20248903

O=C(c1ccccc1)c1ccc(-c2cc3c(-c4ccccc4)c4sccc4c(-c4ccccc4)c3s2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 1/20 0.45
▸ SCD O00767 3/20 0.43
▸ ATM Q13315 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ CNR2 P34972 3/20 0.37
▸ CNR1 P21554 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ SRD5A2 P31213 1/20 0.37
▸ PTP4A3 O75365 1/20 0.36
▸ PTP4A2 Q12974 1/20 0.36
▸ PTP4A1 Q93096 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ PTPN5 P54829 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20248908 0.99 ADORA1 (0.43) ADORA1SCDATMTDP1L3MBTL1
SCHEMBL20248872 0.84 ADORA2A (0.46) ADORA1L3MBTL1MAPTRAB9AMEN1
SCHEMBL20248873 0.83 ADORA2A (0.45) ADORA1MAPTRAB9AMEN1LMNA
SCHEMBL20248879 0.82 PTP4A3 (0.39) L3MBTL1PTP4A3PTP4A2PTP4A1POLB
SCHEMBL20248901 0.81 MEN1 (0.43) ADORA1TDP1MAPTMEN1LMNA
SCHEMBL20248876 0.81 PTP4A3 (0.39) L3MBTL1ALDH1A1PTP4A3PTP4A2PTP4A1
SCHEMBL20248869 0.80 ADORA2A (0.42) ADORA1MAPTRAB9AMEN1LMNA
SCHEMBL20248868 0.79 ADORA2A (0.44) ADORA1MAPTRAB9AALDH1A1PTP4A3
SCHEMBL20248904 0.78 NPC1 (0.44) MAPTRAB9AMEN1KMT2AALDH1A1
SCHEMBL14902909 0.78 PLK4 (0.43) RAB9AMEN1KMT2AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10347846-B2 Organic compound for organic EL device and using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-07-09 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10347846-B2 Organic compound for organic EL device and using the same L1CAM, ESR1, XPO4 ADORA1 912/4885SCD 3900/4885ATM 3446/4885
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME L1CAM, ESR1, XPO4 ADORA1 912/4885SCD 3900/4885ATM 3446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback